A few more dots to join up.
Pacific Edge finishes its 2017 financial year today.
The share price has been very steady lately nudging 60c.
They still await Kaiser Permanente's decision on cxbladder.
They still await CMS approval following further clinical validity and utility published recently in peer reviewed journals.
Any substantial announcement next week from PEB could make life interesting for CDY and its ever hopeful shareholders.
- Forums
- ASX - By Stock
- AN1
- CDY Chart
CDY Chart, page-50
-
-
- There are more pages in this discussion • 204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable